2089 - patents office journal - Irish Patents Office

(09/01/2008) Patents Office Journal (No. 2089)
Supplementary Protection Certificates Granted
The name and address of the grantee follows the number allocated to the application for grant of a certificate;
this number applies also to the granted certificate. The date in brackets following the name and address is the
date of grant of the certificate. The number of the basic Patent and the title of the invention are followed by
the name of the product for which the certificate is granted. Market authorisation references in respect of the
product concerned are also shown, followed by the date of expiry of the certificate.
2006036 ENCYSIVE PHARMACEUTICALS INC., 6700 West Loop South, 4th Floor,
Bellaire, TX 77401, United States of America
14/12/2007
Patent No: 0819125; THIENYL-, FURYL-, PYRROLYL- AND
BIPHENYLSULFONAMIDES AND DERIVATIVES THEREOF THAT
MODULATE THE ACTIVITY OF ENDOTHELIN
Product: Sitaxentan or a pharmaceutically acceptable salt, acid or ester thereof, in
particular sitaxentan sodium
Market Authorisation: Ireland EU/1/06/353/001-005, 10/08/2006
European Union EU/1/06/353/001-005, 10/08/2006
Certificate Expires on: 03/04/2021
2007004 PFIZER INC., 235 East 42nd Street, New York, N.Y. 10017, United States of
America
14/12/2007
Patent No: 72473; Quinuclidine derivatives
Product: Maropitant, or a pharmaceutically acceptable salt of such compound.
Market Authorisation: Ireland EU/2/06/062/001 - 005, 29/09/2006
European Union EU/2/06/062/001 - 005, 29/09/2006
Certificate Expires on: 30/06/2017
2007007 MEDIMMUNE, INC., 35 West Watkins Mill Road, Gaithersburg, MD 20878,
United States of America
14/12/2007
Patent No: 1015561; IN VITRO METHOD FOR
DISASSEMBLY/REASSEMBLY OF PAPILLOMAVIRUS VIRUS-LIKE
PARTICLES (VLPS)
Product: The combination of virus-like particles of human papilloma virus type
6, 11, 16 and 18
Market Authorisation: Ireland EU/1/06/357/001-017, 20/09/2006
Ireland EU1/06/358/001-017, 20/09/2006
Certificate Expires on: 19/09/2021
59